These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 36264766)
1. Targeted Proteomic Analysis of Small GTPases in Radioresistant Breast Cancer Cells. Gao Z; Yang YY; Huang M; Qi TF; Wang H; Wang Y Anal Chem; 2022 Nov; 94(43):14925-14930. PubMed ID: 36264766 [TBL] [Abstract][Full Text] [Related]
2. Targeted Profiling of Heat Shock Proteome in Radioresistant Breast Cancer Cells. Miao W; Fan M; Huang M; Li JJ; Wang Y Chem Res Toxicol; 2019 Feb; 32(2):326-332. PubMed ID: 30596229 [TBL] [Abstract][Full Text] [Related]
3. Roles of Small GTPases in Acquired Tamoxifen Resistance in MCF-7 Cells Revealed by Targeted, Quantitative Proteomic Analysis. Huang M; Wang Y Anal Chem; 2018 Dec; 90(24):14551-14560. PubMed ID: 30431262 [TBL] [Abstract][Full Text] [Related]
4. Targeted Proteomic Analysis Revealed Kinome Reprogramming during Acquisition of Radioresistance in Breast Cancer Cells. Miao W; Bade D; Wang Y J Proteome Res; 2021 May; 20(5):2830-2838. PubMed ID: 33739118 [TBL] [Abstract][Full Text] [Related]
5. Profiling global kinome signatures of the radioresistant MCF-7/C6 breast cancer cells using MRM-based targeted proteomics. Guo L; Xiao Y; Fan M; Li JJ; Wang Y J Proteome Res; 2015 Jan; 14(1):193-201. PubMed ID: 25341124 [TBL] [Abstract][Full Text] [Related]
6. A Targeted Quantitative Proteomic Approach Assesses the Reprogramming of Small GTPases during Melanoma Metastasis. Huang M; Qi TF; Li L; Zhang G; Wang Y Cancer Res; 2018 Sep; 78(18):5431-5445. PubMed ID: 30072397 [TBL] [Abstract][Full Text] [Related]
7. Targeted Proteomic Profiling Revealed Roles of Small GTPases during Osteogenic Differentiation. Yang YY; Soh R; Vera-Colón M; Huang M; Zur Nieden NI; Wang Y Anal Chem; 2023 May; 95(17):6879-6887. PubMed ID: 37083350 [TBL] [Abstract][Full Text] [Related]
8. Comparative Proteomic Analysis of Irradiation-Induced Radioresistant Breast Cancer Cells Using Label-Free Quantitation. Ying Y; Bian L; Meng Y; Zhang M; Yao Y; Bo F; Li D Front Biosci (Landmark Ed); 2023 Oct; 28(10):244. PubMed ID: 37919065 [TBL] [Abstract][Full Text] [Related]
9. Targeted Profiling of Epitranscriptomic Reader, Writer, and Eraser Proteins Accompanied with Radioresistance in Breast Cancer Cells. Qi TF; Miao W; Wang Y Anal Chem; 2022 Jan; 94(3):1525-1530. PubMed ID: 35021009 [TBL] [Abstract][Full Text] [Related]
10. Targeted Quantitative Proteomic Approach for Probing Altered Protein Expression of Small GTPases Associated with Colorectal Cancer Metastasis. Huang M; Wang Y Anal Chem; 2019 May; 91(9):6233-6241. PubMed ID: 30943010 [TBL] [Abstract][Full Text] [Related]
11. Acyl-CoA synthetase-4 mediates radioresistance of breast cancer cells by regulating FOXM1. Kwon YS; Lee MG; Baek J; Kim NY; Jang H; Kim S Biochem Pharmacol; 2021 Oct; 192():114718. PubMed ID: 34358518 [TBL] [Abstract][Full Text] [Related]
12. Targeted Quantitative Proteomic Approach for High-Throughput Quantitative Profiling of Small GTPases in Brain Tissues of Alzheimer's Disease Patients. Huang M; Darvas M; Keene CD; Wang Y Anal Chem; 2019 Oct; 91(19):12307-12314. PubMed ID: 31460748 [TBL] [Abstract][Full Text] [Related]
13. Development and characterisation of acquired radioresistant breast cancer cell lines. Gray M; Turnbull AK; Ward C; Meehan J; Martínez-Pérez C; Bonello M; Pang LY; Langdon SP; Kunkler IH; Murray A; Argyle D Radiat Oncol; 2019 Apr; 14(1):64. PubMed ID: 30987655 [TBL] [Abstract][Full Text] [Related]
14. Proteomic identification of putative biomarkers of radiotherapy resistance: a possible role for the 26S proteasome? Smith L; Qutob O; Watson MB; Beavis AW; Potts D; Welham KJ; Garimella V; Lind MJ; Drew PJ; Cawkwell L Neoplasia; 2009 Nov; 11(11):1194-207. PubMed ID: 19881955 [TBL] [Abstract][Full Text] [Related]
15. Targeted Proteomic Analysis of Small GTPases in Murine Adipogenesis. Yang YY; Huang M; Wang Y Anal Chem; 2020 May; 92(9):6756-6763. PubMed ID: 32237738 [TBL] [Abstract][Full Text] [Related]
16. Overcoming radioresistance of breast cancer cells with MAP4K4 inhibitors. Kwon YS; Lee MG; Kim NY; Nam GS; Nam KS; Jang H; Kim S Sci Rep; 2024 Mar; 14(1):7410. PubMed ID: 38548749 [TBL] [Abstract][Full Text] [Related]
17. RAC1 GTPase promotes the survival of breast cancer cells in response to hyper-fractionated radiation treatment. Hein AL; Post CM; Sheinin YM; Lakshmanan I; Natarajan A; Enke CA; Batra SK; Ouellette MM; Yan Y Oncogene; 2016 Dec; 35(49):6319-6329. PubMed ID: 27181206 [TBL] [Abstract][Full Text] [Related]
18. ABT-737 reverses the acquired radioresistance of breast cancer cells by targeting Bcl-2 and Bcl-xL. Li JY; Li YY; Jin W; Yang Q; Shao ZM; Tian XS J Exp Clin Cancer Res; 2012 Dec; 31(1):102. PubMed ID: 23259599 [TBL] [Abstract][Full Text] [Related]
19. 2-Methoxyestradiol, an endogenous estrogen metabolite, sensitizes radioresistant MCF-7/FIR breast cancer cells through multiple mechanisms. Salama S; Diaz-Arrastia C; Patel D; Botting S; Hatch S Int J Radiat Oncol Biol Phys; 2011 May; 80(1):231-9. PubMed ID: 21392897 [TBL] [Abstract][Full Text] [Related]
20. Ras-related small GTPases RalA and RalB regulate cellular survival after ionizing radiation. Kidd AR; Snider JL; Martin TD; Graboski SF; Der CJ; Cox AD Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):205-12. PubMed ID: 20619549 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]